financial results
-
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31,…
Read More » -
Extremities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial…
Read More » -
Financial
SANUWAVE Announces Record Q4 and FY2023 Revenue
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4…
Read More » -
Financial
Bioretec Ltd’s Annual Report and Financial Statements 2023 published
Bioretec Ltd Company announcement 15 March 2024 at 5:30 p.m. EET TAMPERE, Finland, March 15, 2024 /PRNewswire/ — Bioretec Ltd has today published its 2023…
Read More » -
Financial
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Press Release, March 13, 2024 – Kuros Biosciences – Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7…
Read More » -
Financial
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 revenue of $148.7 million increased 22% compared to prior year WARSAW, Ind., March 06, 2024 (GLOBE…
Read More » -
Financial
Orthofix Reports Fourth Quarter and Full Year 2023 Results
Recent Highlights Fourth quarter 2023 net sales of $200.4 million, an increase of 64% on a reported basis and 7%…
Read More » -
Financial
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
Version 1.0 Surgical System On Track for Cadaveric Testing this SpringAchieves 2023 Cash Burn Objective of $63.4 Million2024 Cash Burn…
Read More » -
Financial
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
Read More » -
Financial
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL…
Read More » -
Financial
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued…
Read More » -
Financial
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
Full year 2023 total revenue grew 37% to $482 million Full year 2023 adjusted EBITDA margin improved ~890 basis points…
Read More » -
Financial
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…
Read More » -
Financial
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced…
Read More » -
Financial
Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results
Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency1 basis Fourth quarter diluted earnings per share were $2.01;…
Read More »